Abstract:Hepatitis B virus (HBV) covalently closed circular (ccc) DNA is essential to the virus life cycle, its elimination during chronic infection is considered critical to a durable therapy but has not been achieved by current antivirals. Despite being essential, cccDNA has not been the major target of high throughput screening (HTS), largely because of the limitations of current HBV tissue culture systems, including the impracticality of detecting cccDNA itself. In response to this need, we have previously developed a proof-of-concept HepDE19 cell line in which the production of wildtype e antigen (HBeAg) is dependent upon cccDNA. However, the existing assay system is not ideal for HTS because the HBeAg ELISA cross reacts with a viral HBeAg homologue, which is the core antigen (HBcAg) expressed largely in a cccDNA-independent fashion in HepDE19 cells. To further improve the assay specificity, we report herein a "second-generation" cccDNA reporter cell line, termed HepBHAe82. In the similar principle of HepDE19 line, an in-frame HA epitope tag was introduced into the precore domain of HBeAg open reading frame in the transgene of HepBHAe82 cells without disrupting any cis-element critical for HBV replication and HBeAg secretion. A chemiluminescence ELISA assay (CLIA) for the detection of HA-tagged HBeAg with HA antibody serving as capture antibody and HBeAb serving as detection antibody has been developed to eliminate the confounding signal from HBcAg. The miniaturized HepBHAe82 cell based assay system exhibits high level of cccDNA-dependent HA-HBeAg production and high specific readout signals with low background. We have also established a HepHA-HBe4 cell line expressing transgene-dependent HA-HBeAg as a counter screen to identify HBeAg inhibitors. The HepBHAe82 system is amenable to antiviral HTS development, and can be used to identify host factors that regulate cccDNA metabolism and transcription.

Establishment of Heparanase Stable Expression Cell Lines

Construction of a lentiviral RNA interference system targeting heparanase based on miR30 and its silencing effect]

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Construction of heparanase gene-targeted small interfering RNA and its gene silencing effect]

Cloning and Expression of Flavobacterium heparinum Heparinase I Gene

[Establishment of a Transgenic Cell Line with Stable Expression of Human CD14].

Construction of Heparanase-Targeted Shrna Expression Vector and Its Gene Silencing Effects

The Establishment and Identification of the Stable Transfectant of HeLa Cell Expressing Human New Gene( PCIA1)

Establishment of Stable Hela Cell Lines Expressing Enzymatically Active Hepatitis C Virus Rna Polymerase

ESTABLISHMENT OF CHO CELL STRAIN THAT CAN HIGHLY EFFICIENTLY EXPRESS HEPATOMA ASSOCIATE ANTIGEN HAb18G

Construction of a stable expression HEK293T engineered cell line adapted to high-density suspension culture

Cloning and Expression of Flavobacteriun heparinum HeparinaseⅡ

Cloning of Human Tissue Kallikrein Gene and Expressing It in CHO Cell

Clonging and Expression of Heparinase III Gene from Flavobacterium heparinum and Characterization of the Recombinant Fusion Enzyme

Establishment of a Cell-Based Assay System for Hepatitis C Virus Serine Protease and Its Primary Applications

Establishment of stable over-expressing human SIRT1 HEK293 cell line

Secretory Expression of Different C-terminal Truncated HCV E1 Proteins in Mammalian Cells and Characterization of the Expressed Products.

Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators

Construction of Recombinant Human Amelogenin Eukaryon Expression Vector and Its Stable Expression in NIH3T3 Cells

Construction of the eukaryotic expression plasmid containing human epidermal growth factor gene with signal peptide

Construction and verification of eukaryotic expression plasmid carring human HO-1 gene